Pages

Thursday, 19 September 2013

Healthy living may 'reverse' cellular ageing

reposted from: http://www.nhs.uk/news/2013/09September/Pages/Healthy-living-may-reverse-cellular-ageing.aspx
Review: Fergus Walsh : http://www.bbc.co.uk/news/health-24114277
crabsallover highlightskey pointscomments / links.

Telomere length is thought to be a genetic-level sign of ageing.
In this study, researchers investigated whether adopting a healthy lifestyle could cause telomerase activity and telomere length to increase. Telomeres are protective DNA and protein "caps" which protect the ends of chromosomes. Telomerase is an enzyme that can add DNA to telomeres, counteracting this shortening.
The researchers found that men who adopted a healthy lifestyle had increased telomere length after five years, whereas telomere length decreased in men who did not change their ways.
While the results of the study are intriguing, this research has significant limitations, including its small sample size – only 10 men were in the intervention group, for example.
Another significant drawback is the assumption that increased telomere length will automatically lead to improved health. This remains unproven. 

Healthy living

The lifestyle intervention used in the study consisted of four components:
All four of these components are associated with improvements in both physical and mental health.

The study was published in the peer-reviewed journal Lancet Oncology.

What did the research involve?

The researchers recruited men with low-risk prostate cancer who had decided not to have radiotherapy or surgery and had instead decided to "watch and wait".
Low-risk prostate cancers are small and progress more slowly than high-risk cancers. "Watchful waiting", where no active treatment is immediately planned, is a common approach because radiotherapy and surgery can have severe side effects, such as urinary incontinence. This approach is often recommended for older men when it is unlikely the cancer will affect their natural life span.

Treatment for prostate cancer

Many men will require no treatment for prostate cancer, depending on the stage and grade of the tumour. Find out more abouttreatment of prostate cancer.
The men participated in two studies: the GEMINAL study and the MENS study. Both studies monitored the men's tumours.
Men participating in the GEMINAL study had a complete lifestyle change. They:
  • ate a diet high in whole foods, plant-based protein, fruits, vegetables, unrefined grains and legumes, and low in fat and refined carbohydrates (meals were provided for the first three months)
  • performed moderate aerobic exercise by walking for 30 minutes per day six days per week
  • managed stress with gentle yoga-based stretching, breathing, meditation, imagery and progressive relaxation for 60 minutes daily
  • had increased social support, with 60-minute support sessions once per week
For the first three months, at each weekly session men in the GEMINAL study:
  • had another hour of moderate exercise supervised by an exercise physiologist
  • had one hour of stress management techniques supervised by a certified stress management specialist
  • attended one hour of support group led by a clinical psychologist
  • attended a one-hour lecture by a dietitian, nurse or doctor during dinner
After the first three months meetings were not compulsory, but patients could continue to meet on their own for two four-hour meetings per month.
Men participating in the MENS study did not have any help to make lifestyle changes.
The researchers monitored whether the men in both studies made lifestyle changes and calculated a lifestyle index score based on diet, stress management, exercise and social support.
Blood samples were taken from the men at the start of the studies and again five years later. The researchers measured telomere length in peripheral blood mononuclear cells (any blood cell with a round nucleus). They also looked at how active the enzyme telomerase was.
The researchers looked at whether there were differences in changes between baseline and five years after the study started between both groups of men. They looked at changes in:
  • telomere length, measured in "single-copy ratio units", a type of measurement used by geneticists to compare the size of telomeres
  • telomerase activity
  • lifestyle index score
  • prostate specific antigen (PSA) concentration
Prostate cancer can increase the production of PSA – a hormone produced by the prostate – although raised PSA levels are also found in many older men without prostate problems.

What were the basic results?

The researchers used information from 10 men participating in the GEMINAL study who underwent comprehensive lifestyle changes and compared them with 25 men who participated in the MENS study (controls).
After five years, men in the lifestyle change group made more lifestyle changes than men in the control group. Therefore, changes in the lifestyle index score were significantly higher in the lifestyle change group.
After five years, telomere length had increased by a median (average) of 0.06 telomere to single-copy gene ratio units in the lifestyle change group. It had decreased by 0.03 telomere to single-copy gene ratio units in the control group. The difference in changes was statistically significant.
When men from both groups were combined, it was found that improvements in lifestyle were significantly associated with changes in telomere length. For each per cent increase in lifestyle index score, the relative telomere length increased by 0.07 telomere to single-copy gene ratio units after adjustment for age and length of follow-up.
After five years, there was no significant difference in change in telomerase activity (the ability of the  enzyme telomerase extracted from cells to add DNA to telomeres) between the two groups, and telomerase activity was not found to be associated with changes in lifestyle.
There was also no significant difference in change in prostate specific antigen (PSA) concentrations between the two groups.

How did the researchers interpret the results?

The researchers concluded that a "comprehensive lifestyle intervention was associated with increases in relative telomere length after five years of follow-up, compared with controls, in this small pilot study. Larger randomised controlled trials are warranted to confirm this finding."

Conclusion

This interesting study has found that a comprehensive lifestyle intervention was associated with increases in relative telomere length after five years of follow-up in men with prostate cancer.
However, this is a small non-randomised study and it is possible that there are unknown sources of bias. The men came from different trials and they may have differed in other unknown ways. A randomised controlled trial is the only way to counteract this bias and this type of study needs to be performed to confirm these findings.
This research does not show whether lifestyle changes increase telomere length in groups of people other than men with prostate cancer.
Finally, although increases in relative telomere length are thought to be beneficial, it is not clear what, if any, impact this had on the men's health. For example, do longer telomeres mean a better prognosis for men with prostate cancer? 

Hopefully these questions will be answered if further research is carried out.

Analysis by Bazian. Edited by NHS Choices. Follow Behind the Headlines on Twitter.



Sunday, 25 August 2013

Health myths: Being a bit overweight shortens life

reposted from: http://www.newscientist.com/article/mg21929311.100
crabsallover highlightskey pointscomments / links.


Health myths: Being a bit overweight shortens life
26 August 2013 by Caroline Williams

Let's be clear – being seriously obese is bad for your health. A body mass index of over 40 increases the risk of type 2 diabetes, heart disease and certain cancers and increases the risk of dying from any cause by up to 29 per cent. This is not a health myth.

But carrying just a few extra pounds, far from being a one-way ticket to an early grave, seems to deter the grim reaper, according to a recent review of nearly a hundred studies involving nearly 3 million people. The review, led by Katherine Flegal of the US Centers for Disease Control in Hyattsville, Maryland, reported earlier this year that being "overweight" – defined as having a body mass index (BMI) of 25 to 29 – seems to have a protective effect, with a 6 per cent ...

details: http://www.ncbi.nlm.nih.gov/pubmed/23280227
RESULTS:
Random-effects summary all-cause mortality Hazard Ratios (HRs) for overweight (BMI of 25-<30), obesity (BMI of ≥30), grade 1 obesity (BMI of 30-<35), and grades 2 and 3 obesity (BMI of ≥35) were calculated relative to normal weight (BMI of 18.5-<25). The summary HRs were 0.94 (95% CI, 0.91-0.96) for overweight, 1.18 (95% CI, 1.12-1.25) for obesity (all grades combined), 0.95 (95% CI, 0.88-1.01) for grade 1 obesity, and 1.29 (95% CI, 1.18-1.41) for grades 2 and 3 obesity. These findings persisted when limited to studies with measured weight and height that were considered to be adequately adjusted. The HRs tended to be higher when weight and height were self-reported rather than measured.

CONCLUSIONS AND RELEVANCE:
Relative to normal weight, both obesity (all grades) and grades 2 and 3 obesity were associated with significantly higher all-cause mortality. Grade 1 obesity overall was not associated with higher mortality, and overweight was associated with significantly lower all-cause mortality. The use of predefined standard BMI groupings can facilitate between-study comparisons.

Full details: http://jama.jamanetwork.com/article.aspx?articleid=1555137


Comment: http://jama.jamanetwork.com/article.aspx?articleid=1555137#COMMENT - lists strengths and weakness.

"... Our study also has limitations. It addresses only all-cause mortality and not morbidity or cause-specific mortality. It addresses only findings related to BMI and not to other aspects of body composition such as visceral fat or fat distribution..."

NHS Direct review

"However, a slight increase in lifespan doesn’t necessarily equate to an increased quality of life. Even being ‘just’ overweight can increase the chance of developing long-term health conditions, which while may not be fatal, can make life a lot less enjoyable."

and

"The headlines also did not make clear that the increase in life expectancy in people who were overweight or ‘mildly’ obese was modest – they were only 6% less likely to have died by the end of the study period than those of a healthy weight."

Methods

This systematic review included a meta-analysis of 97 studies comprising data on 2.88 million people and 270,000 deaths.

Conclusion

This systematic review provides high-quality evidence that obesity grades 2 and 3 are associated with higher death rates from any cause compared to normal weight individuals (around 30% increased risk). However, it also shows that lower grades of obesity (grade 1) do not increase the risk of death relative to normal-weight individuals and, in fact, overweight people had a small but significant reduction in their risk of death in the region of 6%.

The strengths of this review include the large number of studies it included and its standardised approach to searching and extracting data from the literature. Hence, we can be reasonably confident these results reflect reality.

However, a limitation of the study is that it only assessed the risk of dying from any cause (‘all-cause’ mortality), rather than death from specific diseases such as cancer, heart disease or diabetes. The association between weight and risk of death for different disease categories may vary. Disability and living with long-term diseases are also important to people and some conditions such as diabetes may show stronger links with weight at lower thresholds of BMI.

The review also crucially chose BMI as the measure of weight, which has been mistakenly taken by the media to mean an accurate measure of unhealthy ‘fatness’. BMI is a pragmatic choice to assess weight but it does not account for other known disease and death risk factors such as differing fat levels, fat distribution, muscularity, nutritional balance and others. BMI is also an imperfect measure of fatness as it only measures weight and height. Hence, those who are overweight are not all necessarily overweight because they are carrying excess fat. For instance, someone who is very muscular can have a high BMI and therefore be categorised as overweight.

Other measures such as waist circumference offer alternative ways of quickly estimating a person’s body fat levels and whether they are of a healthy weight. In practice, BMI is not the only measure used when establishing risk of disease or death. Doctors will be checking for a host of risk factors like high blood pressure, high cholesterol and high blood glucose levels in addition to BMI and/or waist circumference. Hence, the BMI category is only one of many measures used by a doctor to assess health, and by no means the best.

The finding that overweight individuals were at slightly less risk of dying than their normal-weight counterparts had been reported in research before (this is often referred to as the obesity paradox).

Possible explanations why a bit of extra weight may extend life include:

  • People with more fat reserves to rely on may survive better if they lose weight due to ill health as they get older.
  • Problems associated with being overweight (high blood pressure and diabetes) are picked up and treated earlier in overweight people compared with normal weight, as doctors are more vigilant of risk factors in overweight people. This treatment improves their health overall.

However, it is important to note that these are largely unsubstantiated theories and have not been further explored or proven.

The bottom line is that being obese (all categories combined) increased the chance of dying compared to those with a normal BMI. This was not the case for overweight individuals or the lowest category of obesity (grade 1) on its own.

It is important to consider that individual risk factors for developing disease and death will vary person to person and BMI is only one of many measures used to assess the risk of developing disease in the future.

Even if you choose to ignore the limitations of this research, it would be unwise to interpret its findings as proof that being overweight is ‘healthy’ – rather it may be slightly less unhealthy than perceived.

source: http://www.nhs.uk/news/2013/01january/pages/overweight-people-live-longer-study-claims.aspx

Change4Life '150 minutes active exercise per week'

reposted from: http://www.nhs.uk/change4life/pages/get-going-every-day.aspx
crabsallover highlightskey pointscomments / links.


Building activity into your day keeps your heart healthy, reduces your risk of serious illness and strengthens muscles and bones. It can also be a great way of reducing your stress levels and lifting your mood if you’re feeling down.

That means:

  • Adults needs to be active for at least 150 minutes each week
    • Being active means getting your heart rate up, feeling warmer (perhaps even breaking into a light sweat) and making your lungs work harder.